Skip to main content
Tetra Bio-Pharma Logo
  • About
    • Company Overview
    • Corporate Policies
    • Governance Policies
    • Team
    • Partners
    • Careers
  • Research
    • Clinical Trials
    • Publications
  • Pipeline
  • Investors
  • Newsroom
  • Contact
Facebook Twitter Linkedin
MENU
  • Home
  • About
    • Company Overview
    • Team
    • Partners
    • Careers
    • Patient Resource
  • Pipeline
  • Investors
  • Newsroom
  • Contact
  • Home
    • Investors
      • Overview
      • Events and Presentations
      • Stock Info
      • Financials
      • Governance
        • Board of Directors
        • Executive Management
        • Committee Composition
      • Resources
        • Shareholder Info
        • FAQs
        • Email Alerts
    • Newsroom
      • Press Releases
      • Videos

Press Releases

  • Home
    • Investors
      • Overview
      • Events and Presentations
      • Stock Info
      • Financials
      • Governance
        • Board of Directors
        • Executive Management
        • Committee Composition
      • Resources
        • Shareholder Info
        • FAQs
        • Email Alerts
    • Newsroom
      • Press Releases
      • Videos
Normal
Press Release RSS Feed (opens in new window)
Press release year list 2022 2021 2020 2019 2018 2017 2016
05/18/2022
Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD
05/17/2022
Tetra Bio-Pharma Announces Closing of First Tranche with Cannvalate
05/10/2022
Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology
05/05/2022
Tetra Bio-Pharma and Cannvalate Enter Into Partnership
03/17/2022
Tetra Bio-Pharma's QIXLEEF™ on Track After Type C Meeting with U.S. FDA
03/08/2022
Tetra Bio-Pharma Provides Update on Research Collaboration with the University of Montreal Hospital Research Centre for Inhaled CBD
02/28/2022
Tetra Bio-Pharma Provides Management Update
02/22/2022
Tetra Bio-Pharma Signs License Agreement with Thorne for a Prebiotic Dietary Supplement
02/16/2022
Tetra Bio-Pharma Receives $4.5M from the Ministère de l'Économie et de l'Innovation/Investissement Québec
02/16/2022
Tetra Bio-Pharma reçoit un appui financier de 4,5 M$ du ministère de l'Économie et de l'Innovation/Investissement Québec
02/14/2022
Tetra Bio-Pharma Enters into a Strategic Partnership with Avicanna

TETRA BIO-PHARMA

Company Overview
Team
Partners
Careers

Pipeline
Investors
Press Releases
Videos

INFORMATION

Corporate Policies
Governance Policies
Terms of Service
Privacy Policy
Contact Us

FOLLOW US

Facebook Twitter Linkedin
Girl in a jacket
Tetra Bio-Pharma Logo

Copyright © 2019. Tetra Bio-Pharma
All rights reserved.

Powered By Q4 Inc. 5.71.0.1 (opens in new window)